期刊文献+

中药安全性评价:新时代,新策略

Safety evaluation of traditional Chinese medicine:new era,new strategy
下载PDF
导出
摘要 当今,随着中药在全球范围内使用越来越广泛,中药安全性领域出现了诸多新问题和新挑战,特别是传统“无毒”中药频频曝出肝损伤、肾损害等安全性问题/事件,颠覆了人们对中药毒性与安全性的传统认知,也给中医药健康及国际化带来了巨大挑战。那么如何客观认识中药安全性的形势及问题?如何科学破解中药安全性评价与风险防控难题?,本团队提出:一是要与时俱进,辨证看待中药安全性问题和形势,不要夸大,也不要小视;二是要突破“唯药物论毒性”的传统认知,创新中药毒性理论与安全性评价模式;三是要针对不同毒性类型中药,建立安全风险精准防控对策,推动中药安全风险管理从被动应对向科学主动防控转变。在此基础上,提出了“中药新安全观”思想及方法体系,希冀为系统性地破解中药安全性评价与风险防控难题提供新理论、新策略、新方法及成功范例。 Today,as the use of traditional Chinese medicine(TCM)becomes widespread globally,TCM is confronted with numerous new safety issues and challenges.In particular,the frequent emergence of safety issues/events such as liver and kidney injury associated with traditionally“non-toxic”TCM has overturned the conventional understanding of the toxicity and safety of TCM.This has also posed significant challenges to the development and internationalization of TCM.So,how should we understand the situation and problems of TCM safety?How can we scientifically solve the problems in evaluation and risk control of TCM?Our team proposes the following:First,we must keep pace with the times and view the issues of TCM safety in a dialectical manner,without exaggeration or underestimation.Second,we must break through the traditional perception that toxicity only came from the medicine itself,and innovate the theories of TCM toxicity.Third,we must establish precise prevention and control strategies for TCM with different types of toxicity,promoting a shift in the management of TCM safety risks from passive response to scientific and proactive control.On this basis,we have put forward the concept and methodological system of the“New Outlook on TCM safety”,hoping to provide new theories,strategies,methods,and successful examples for systematically solving the problems in the evaluation and risk control of TCM.
作者 赵旭 柏兆方 湛小燕 王伽伯 郑永齐 肖小河 Xu Zhao;Zhaofang Bai;Xiaoyan Zhan;Jiabo Wang;Yungchi Cheng;Xiaohe Xiao(Department of Hepatology,The Fifth Medical Centre of Chinese PLA General Hospital,Beijing,China;School of Traditional Chinese Medicine,Capital Medical University,Beijing,China;Consortium for the Globalization of Chinese Medicine,Yale University,New Haven,CT,USA)
出处 《Acupuncture and Herbal Medicine》 2024年第2期171-175,I0004,共6页 针灸和草药(英文)
基金 supported by the National Natural Science Foundation of China (81721002,82230118) the Consulting Project Funds of the Chinese Academy of Engineering (2023-XZ-88)。
关键词 肝毒性 中药新安全观 风险防控 安全性评价 中药 Hepatotoxicity New Outlook on TCM Safety Risk prevention Safety evaluation TCM
  • 相关文献

参考文献10

二级参考文献90

  • 1Jing Jing,Rolf Teschke.Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury[J].Journal of Clinical and Translational Hepatology,2018,6(1):57-68. 被引量:26
  • 2英国MHRA警告何首乌的肝损害不良反应[J].中国药物警戒,2006,3(5):313-314. 被引量:24
  • 3许建明.全国多中心急性药物性肝损伤住院病例调研分析[J].中华消化杂志,2007,27(7):439-442. 被引量:88
  • 4World Health Organization. WHO Collaborating Center for Drug Monitoring. The importance of pharmacovigilance. 2002.
  • 5O'neill RT. Biostatistical considerations in pharmacovigilance and pharmacoepidemiology: linking quantitative risk assessment in premarket licensure application safety data, post-market alert reports and formal epidemiological studies, StatistMed, 1998,17: 1851-1858.
  • 6Waller PC,Lee EH. Responding to drug safety issues. Pharmacoepidemiology and Drug Safety, 1999, 8: 535-552.
  • 7Bennett CL, Nebeker JR, Lyons EA, et al. The research on adverse events and reports (RADAR) project, JAMA, 2005, 293: 2131-2140.
  • 8Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance. British Journal of Clinical Pharmacology, 2003, 57(2): 127-134.
  • 9Hauben M,Zhou Xiaofeng.Quantitative methods in pharmacovigilance. Drug Safety, 2003, 26(3): 159-186.
  • 10Rothman KJ, Greenland S. Modern Epidemiology(2nd edition). Lippincott: Williams&Wilkins, 1998.

共引文献316

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部